Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

71% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (10)
P 3 (1)
P 4 (1)

Trial Status

Completed5
Unknown5
Terminated2
Recruiting1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
Showing all 13 trials

Research Network

Activity Timeline